Monte Rosa Therapeutics, Inc.
USD23.90
+1.61 (+7.22%)
CEO
Markus Warmuth
IPO Date
2021-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.59
Prev. Close
$22.29
Day Low
$22.59
Day High
$23.98
52W Low
$4.12
52W High
$25.77
Market Cap
$1.56B
Volume
1.84M
| -7.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -75.5% | -44.6% | 0.26 | 5.07 | -2.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -40.0% | -31.7% | 0.17 | 10.79 | -3.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -21.3% | -20.2% | 0.00 | 20.96 | -12.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 73.6% | -72.7% | -1.39 | 1.49 | -26.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 66.0% | -72.3% | -0.06 | 2.27 | -116.3 |
| -5.6 |
| 30 Sept 2025 | Q3 | 100.0% | -212.1% | -11.0% | -5.9% | 0.16 | 6.54 | -5.6 |
| 30 Jun 2025 | Q2 | 100.0% | -53.0% | -4.6% | -3.4% | 0.15 | 7.16 | -7.5 |
| 31 Mar 2025 | Q1 | 100.0% | 55.2% | 17.0% | 11.9% | 0.15 | 5.61 | 2.0 |
| 31 Dec 2024 | Q4 | 100.0% | 22.2% | 6.0% | 3.1% | 0.19 | 2.40 | 7.9 |
| 30 Sept 2024 | Q3 | 100.0% | -258.9% | -11.6% | -7.6% | 0.21 | 6.03 | -4.6 |
| 30 Jun 2024 | Q2 | 56.1% | -645.6% | -13.5% | -8.8% | 0.20 | 6.56 | -2.3 |
| 31 Mar 2024 | Q1 | -78.3% | -3004.5% | -21.0% | -12.0% | 0.30 | 4.82 | -3.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -18.6% | -10.9% | 0.26 | 5.07 | -2.4 |